OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
5.31
+0.86 (19.48%)
Sep 2, 2026, 1:13 PM EDT - Market open
OmniAb Revenue
OmniAb had revenue of $13.42M in the quarter ending June 30, 2026, with 244.24% growth. This brings the company's revenue in the last twelve months to $38.46M, up 67.01% year-over-year. In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%.
Revenue (ttm)
$38.46M
Revenue Growth
+67.01%
P/S Ratio
16.79
Revenue / Employee
$432,101
Employees
89
Market Cap
771.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.67M | -7.73M | -29.27% |
| Dec 31, 2024 | 26.39M | -7.77M | -22.75% |
| Dec 31, 2023 | 34.16M | -24.91M | -42.17% |
| Dec 31, 2022 | 59.08M | 24.33M | 70.02% |
| Dec 31, 2021 | 34.75M | 11.48M | 49.34% |
| Dec 31, 2020 | 23.27M | 4.95M | 27.02% |
| Dec 31, 2019 | 18.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CorMedix | 462.25M |
| MiMedx Group | 355.17M |
| REGENXBIO | 174.48M |
| Valneva SE | 163.30M |
| Autolus Therapeutics | 117.39M |
| Allogene Therapeutics | 4.64M |
| Prime Medicine | 4.07M |
OABI News
- 7 days ago - OmniAb to Participate in Upcoming Investor Conferences - Business Wire
- 16 days ago - OmniAb raises FY26 cash and equivalents view to $49M-$53M vs. $37M-$41M - TheFly
- 16 days ago - OmniAb Raises 2026 Financial Guidance - Business Wire
- 16 days ago - OmniAb announces collaboration and license agreement with Eli Lilly - TheFly
- 16 days ago - OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company - Business Wire
- 23 days ago - OmniAb Slides: Corporate presentation - Filings
- 26 days ago - OmniAb reports Q2 EPS (5c), consensus (13c) - TheFly
- 26 days ago - OmniAb raises FY26 revenue view to $32M-$36M from $28M-$33M - TheFly